Ascent Pharmaceuticals Inc. received FDA approval for the ANDA210506 of Hydromorphone Hydrochloride Tablets, offering a potential additional oral gene...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Fresenius Kabi USA announced the spread of the 50 mg/RBC units FDA approval for remifentanil hydrochloride injections, removing a regulatory hurdle th...
# FDA Approves Generic Drug Application for Amneal Pharmaceuticals Amneal Pharmaceuticals received FDA approval for ANDA210040 on December 22, 2017, ...
On December 20, 2017, the FDA approved macimorelin (Macrilen), developed by Aeterna Zentaris GmbH, marking a significant milestone as the first endoge...
# FDA Approves Merck's STEGLUJAN Combination Therapy for Type 2 Diabetes Merck Sharp & Dohme LLC received FDA approval for STEGLUJAN (ertugliflozin a...
# FDA Approves Merck's STEGLATRO (Ertugliflozin) for Type 2 Diabetes Merck Sharp & Dohme LLC received FDA approval for STEGLATRO (ertugliflozin), an ...
Merck Sharp & Dohme LLC received FDA approval on Dec. 19, 2017, for Segluromet, a fixed-dose tablet containing ertugliflozin and metformin, which is p...
# FDA Approves Generic Zoledronic Acid Intravenous Formulation Eugia US LLC has received FDA approval for its generic zoledronic acid intravenous for...
# FDA Approves Novo Nordisk's Ozempic for Type 2 Diabetes Treatment Novo Nordisk Pharmaceutical Industries, LP received FDA approval for Ozempic (sem...
Zhejiang Hisun Pharm has received FDA approval for the generic version of S Combipres (ncludpril & clonidine) indicated for hypertension, securing a s...
AstraZeneca announced on November 14, 2017, that the FDA granted full approval for its blockbuster respiratory drug FASENRA, the subcutaneous formulat...
Zhejiang Hisun Pharmaceutical has received FDA approval for its ANDA 204077, a pivotal move that sets the stage for commercial entry into the U.S. mar...
# FDA Approves AstraZeneca's CALQUENCE (acalabrutinib) for Blood Cancer Treatment AstraZeneca Pharmaceuticals LP received FDA approval for CALQUENCE ...
Eywa Pharma Inc secured FDA approval for its ANDA 210211 covering Hydrocodone Bitartrate and Acetaminophen oral tablets, thereby granting the company ...
1. **Analyze the Request:** * **Topic:** FDA drug approval (generic hydromorphone hydrochloride). * **Key Data:** * Brand/Subst...
Actavis Elizabeth announced the approval of its abbreviated new drug application [INSERT GENERIC NAME] by the FDA, marking a significant entry for the...
Amneal Pharmaceuticals has announced the launch of isotretinoin, completing FDA approval following the filing of ANDA 207792. This entry into the mark...
On September 25, 2017, Lannett Company received FDA approval for a generic drug indicated by ANDA207333, positioning the company for potential market ...
# FDA Approves Actelion Pharmaceuticals' TRACLEER (bosentan) Oral Formulation Actelion Pharmaceuticals US, Inc. received FDA approval for TRACLEER (b...
Zydus Pharmaceuticals has received approval from the Food and Drug Administration (FDA) for ANDA 204473, marking a strategic entry into the market tha...